Follow
Vincent Lo Re III, MD, MSCE
Vincent Lo Re III, MD, MSCE
Associate Professor of Medicine & Epidemiology, University of Pennsylvania
Verified email at pennmedicine.upenn.edu - Homepage
Title
Cited by
Cited by
Year
The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis
BR Yehia, AJ Schranz, CA Umscheid, V Lo Re III
PloS one 9 (7), e101554, 2014
4832014
Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C Virus–monoinfected patients: a cohort study
VL Re III, MJ Kallan, JP Tate, AR Localio, JK Lim, MB Goetz, MB Klein, ...
Annals of internal medicine 160 (6), 369-379, 2014
3132014
Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection
AIHCVG Panel
Clinical infectious diseases: an official publication of the Infectious …, 2018
3052018
Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study
CT Rentsch, F Kidwai-Khan, JP Tate, LS Park, JT King Jr, M Skanderson, ...
PLoS medicine 17 (9), e1003379, 2020
2922020
A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression
R Gross, B Yip, VL Re III, E Wood, CS Alexander, PR Harrigan, ...
The Journal of infectious diseases 194 (8), 1108-1114, 2006
2422006
HCV epidemiology in high-risk groups and the risk of reinfection
H Midgard, A Weir, N Palmateer, VL Re III, JA Pineda, J Macías, ...
Journal of hepatology 65 (1), S33-S45, 2016
2182016
Eosinophilic meningitis
VL Re III, SJ Gluckman
The American journal of medicine 114 (3), 217-223, 2003
1912003
The short‐term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct‐acting antivirals: An ERCHIVES study
DK Li, Y Ren, DS Fierer, S Rutledge, OS Shaikh, VL Re III, T Simon, ...
Hepatology 67 (6), 2244-2253, 2018
1722018
Covid-19 testing, hospital admission, and intensive care among 2,026,227 United States veterans aged 54–75 years
CT Rentsch, F Kidwai-Khan, JP Tate, LS Park, JT King Jr, M Skanderson, ...
MedRxiv, 2020
1662020
Validity of diagnostic codes and liver‐related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study
VL Re III, JK Lim, MB Goetz, J Tate, H Bathulapalli, MB Klein, D Rimland, ...
Pharmacoepidemiology and drug safety 20 (7), 689-699, 2011
1512011
Validation of three coding algorithms to identify patients with end‐stage liver disease in an administrative database
D Goldberg, JD Lewis, SD Halpern, M Weiner, V Lo Re III
Pharmacoepidemiology and drug safety 21 (7), 765-769, 2012
1472012
Disparities in absolute denial of modern hepatitis C therapy by type of insurance
VL Re III, C Gowda, PN Urick, JT Halladay, A Binkley, DM Carbonari, ...
Clinical Gastroenterology and Hepatology 14 (7), 1035-1043, 2016
1442016
Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the …
KN Althoff, KA Gebo, RD Moore, CM Boyd, AC Justice, C Wong, ...
The lancet HIV 6 (2), e93-e104, 2019
1232019
Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system
DS Goldberg, KA Forde, DM Carbonari, JD Lewis, KBF Leidl, KR Reddy, ...
Gastroenterology 148 (7), 1353-1361. e3, 2015
1172015
The Yale cTAKES extensions for document classification: architecture and application
V Garla, VL Re III, Z Dorey-Stein, F Kidwai, M Scotch, J Womack, A Justice, ...
Journal of the American Medical Informatics Association 18 (5), 614-620, 2011
1172011
Covid-19 by race and ethnicity: a national cohort study of 6 million United States veterans
CT Rentsch, F Kidwai-Khan, JP Tate, LS Park, JT King Jr, M Skanderson, ...
MedRxiv, 2020
1152020
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease management, COVID …
JM Gelfand, AW Armstrong, S Bell, GL Anesi, A Blauvelt, C Calabrese, ...
Journal of the American Academy of Dermatology 84 (5), 1254-1268, 2021
1122021
Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients
M DallaPiazza, VK Amorosa, R Localio, JR Kostman, V Lo Re
BMC infectious diseases 10, 1-7, 2010
1112010
Risk of end-stage liver disease in HIV-viral hepatitis coinfected persons in North America from the early to modern antiretroviral therapy eras
MB Klein, KN Althoff, Y Jing, B Lau, M Kitahata, V Lo Re III, GD Kirk, ...
Clinical Infectious Diseases 63 (9), 1160-1167, 2016
1032016
Nonantiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals
AC Justice, KS Gordon, M Skanderson, EJ Edelman, KM Akgün, ...
Aids 32 (6), 739-749, 2018
932018
The system can't perform the operation now. Try again later.
Articles 1–20